Featured Posts
Blog
New FDA lab tests rule could bankrupt small labs
Yesterday the Food and Drug Administration (FDA) announced that on May 6 it will promulgate a rule under its authority to regulate medical devices.
City Journal
A Solution in Search of a Problem
In his State of the Union address, President Biden touted the drug-price controls in his Inflation Reduction Act (IRA). Though the price controls have yet…
City Journal
Ignoring the Science
A new CDC study reports that the first updated Covid-19 vaccine—the bivalent vaccine approved in fall 2022—was about 50 percent effective in blocking infection over a two-month…
Search Posts
Blog
New FDA lab tests rule could bankrupt small labs
Yesterday the Food and Drug Administration (FDA) announced that on May 6 it will promulgate a rule under its authority to regulate medical devices.
City Journal
A Solution in Search of a Problem
In his State of the Union address, President Biden touted the drug-price controls in his Inflation Reduction Act (IRA). Though the price controls have yet…
City Journal
Ignoring the Science
A new CDC study reports that the first updated Covid-19 vaccine—the bivalent vaccine approved in fall 2022—was about 50 percent effective in blocking infection over a two-month…
The Federalist Society
Explainer 62 – FDA’s Regulation of Laboratory Developed Tests
CEI’s Joel Zinberg joined a podcast hosted by The Federalist Society for the Regulatory Transparency Project on the FDA’s regulation of laboratory developed tests:…
National Review
When Science Is Not Science
Just 22 percent of all adults and 41 percent of those 65 and older — the most vulnerable group — have received the updated 2023–24 Covid-19 vaccine.
Washington Times
Cutting-edge drugs could vanish under Biden’s unprecedented move to seize patents
CEI’s Dr. Joel Zinberg is cited in the Washington Times on the Biden Administration’s move to seize patents: Dr. Joel Zinberg, a senior fellow…
National Review
Another FDA Power Grab
The comment period for the Food and Drug Administration’s latest power grab has just concluded. Roughly 20,000 comments were submitted addressing the FDA’s proposed rule which…
News Release
CEI leads coalition calling on Congress to repeal drug price control provisions of the Inflation Reduction Act
The Competitive Enterprise Institute (CEI) and a coalition 43 conservative and free market groups sent a letter to Congress today calling for the…
Letters
Coalition Letter to End IRA Prescription Drug Price Controls
October 31, 2023 Dear Members of Congress, When the Inflation Reduction Act was passed and signed into law a year ago, the legislation granted the…
National Review
Restricting Pharmacy Benefit Managers Could Decrease Competition and Increase Drug Costs
Congress is considering multiple bills that aim to restrict the ability of pharmacy benefit managers (PBMs) to negotiate discounts and rebates and to require the PBMs…
Wall Street Journal
Court to FDA: Stop Playing Doctor
The Food and Drug Administration regulates pharmaceuticals, but it has no business playing doctor and giving you medical advice. That’s the message of a Sept.
Washington Examiner
The Biden administration shouldn’t waste more taxpayer dollars on COVID vaccines
A Food and Drug Administration advisory committee recently voted to recommend updating the COVID-19 vaccine. But important questions remain: When…
The Center Square
Fauci takes heat after casting doubt on efficacy of COVID vaccines
CEI’s Joel Zinberg is cited in The Center Square on COVID vaccines: Joel Zinberg, a Competitive Enterprise Institute senior fellow, blasted Fauci for pushing for…
Blog
New Inflation Numbers Show Folly of Price Controls
Today’s release of inflation numbers by the Bureau of Labor Statistics confirms that the loudest voices in favor of price controls are usually the…
Letters
CEI Joins Coalition Opposing March-In over Drug Prices
Dear Secretary Becerra, On behalf of millions of Americans across the country, we urge you to ignore calls and petitions asking you to deliberately twist…
Letters
CEI Joins Coalition Urging Congress to End Ban on DC Marijuana Sales
Dear Members of Congress, As you and your colleagues in Congress continue to finalize funding levels and bill language in the FY22 appropriations bill, the…
Letters
CEI Joins NTU-Led Coalition Warns of BBB’s Impact on Drug Competition
Dear Senators and Representatives: On behalf of the undersigned organizations — taxpayer, consumer, and free market advocates from across the country — we write with…
Letters
CEI Joins ATR Led Drug Price Control Coalition Letter
Dear Member of Congress: We write in opposition to the Democrat plan to impose price controls, a 95 percent excise tax, and inflation penalties on…
National Review
Innovators to the Rescue
Thirty years ago, I spoke at a conference on xenotransplantation — the transplantation of organs, cells, or tissues between species — at Columbia…
Blog
Democrats’ Drug Price Control Bill Is a Prescription for Disaster
Last Thursday, House Democrats reintroduced a bill from the last Congress, which they claim will protect Medicare from excessive prescription drug prices. Sadly, it…
Blog
More Good News on the Road to Ending the Pandemic
A new study from the Center for Disease Control and Prevention, which shows that a single dose of either the Pfizer-BioNTech or the Moderna…
Blog
Prescription Drug Price Controls are a Trump Legacy Worth Eradicating
During his first month in office, President Biden has seemingly been more interested in eradicating Donald Trump’s legacy than pushing his own proposals, though…
Blog
Employers Will Pay Workers to Get a Covid-19 Vaccine
The federal government, through Operation Warp speed, helped develop and bring to market vaccines against the new disease COVID-19 in less than a year, an…
Blog
COVID-19 Vaccine Development Is Testament to the Market’s Ability to Develop Life-Saving New Products
The announcement by drug maker Moderna that preliminary data from its still ongoing trial shows its COVID-19 vaccine is 95 percent effective is extremely encouraging.
Blog
New CEI Report: Making Sure a COVID-19 Vaccine Is Used
One or more COVID-19 vaccines will likely be approved in the next few months. But this scientific achievement may prove to be the easy part.
City Journal
Following The Science — Where?
When doctors meet a patient for a new complaint, we make a list of different possible explanations for the problem—a differential diagnosis—and try to determine…
News Release
CEI Welcomes Senior Fellow with Health Care and Legal Expertise
The Competitive Enterprise Institute is pleased to welcome medical and legal expert Joel M. Zinberg, M.D., J.D. as a senior fellow working on health care…
Blog
How SEC Accounting Regulations Hindered National Stockpile—and Still May Be Doing So
In a new report, CEI experts outline #NeverNeeded regulations that are frustrating responses to the pandemic and its aftermath. Among those is an obscure Securities…
Blog
Getting Rid of #NeverNeeded Regulations Hindering Coronavirus Response
What can Washington do to minimize harm from the coronavirus? Some of the best policy responses are coming not from imposing new regulations, but from…
Blog
Liberty in the Time of Coronavirus Part 2
Much of the money dedicated to medical research and services comes from the federal government. While some may see this is a good way to…
Blog
Regulation, Confusion, and the Irony of Emergency COVID-19 Testing
By now, readers are aware that testing in the United States for the novel coronavirus COVID-19 has been embarrassingly slow. Less well known is that…
Blog
Trump Administration Expected to Adopt Socialized Medicine Drug Pricing Control Scheme
Regardless of the outcome of the Iowa Caucuses on Monday night, the successive presidential campaigns of Democratic Socialist Senator Bernie Sanders (I-VT) have dragged the…
Fox News
Pelosi, Progressive Caucus Clash over Drug Pricing Legislation
Fox News cites Research Fellow Patrick Hedger on Nancy Pelosi’s proposed “Lower Drug Costs Now Act.” But according to the right-leaning Competitive Enterprise…
News Release
House Bill Setting Price Controls on Medicines Would Endanger Patients, Harm Innovation
House Speaker Nancy Pelosi and Majority Leader Steny Hoyer plan to bring H.R. 3, the Lower Drug Costs Now Act, to the floor for a…
Real Clear Markets
With Drug Pricing, Bipartisanship Isn’t an Excuse to Violate the Laws of Economics
In an age of intense political polarization, some may assume anything that House Speaker Nancy Pelosi and President Donald Trump even marginally agree on has…
The Economic Standard
Drug Reference Pricing Threatens Patient Health, Innovation
The Economic Standard cites Research Fellow Patrick Hedger and CEI’s event on drug reference pricing: Some recent proposals to lower drug prices are…
News Release
Foreign Reference Pricing Schemes Threaten Patient Health and America’s Leadership in Medical Innovation
International policy experts and patients gathered today in Washington, D.C. to discuss the potential impact of foreign reference pricing schemes, which have been proposed by the…
News Release
International Experts Voice Concerns About International Pricing Index and Foreign Reference Pricing Proposals for Prescription Drugs
To address the cost of prescription medicines, the Trump administration and congressional leaders have proposed instituting international reference pricing policies, like the International Pricing Index…
Letters
CEI Joins Coalition Letter Opposing Pelosi Drug Tax Plan
Dear Members of Congress: We write in opposition to the prescription drug pricing bill offered by House Speaker Nancy Pelosi that would impose an excise…
Blog
Bogus E-cigarette Panic Literally Killing People
Is this a story from The Onion? It’s a question we often ask ourselves these days when we encounter stories online that seem too ridiculous…
Letters
CEI Joins Coalition Letter to Urge President Trump to Halt Regulatory Assault on Innovative Electronic Cigarette Industry
We urge you to immediately halt the Food and Drug Administration’s aggressive regulatory assault on businesses who sell and consumers who rely on less harmful…
Marijuana Moment
Congress Clashes On Marijuana Amendments In Floor Debate
Marijuana Moment cites Senior Fellow Michelle Minton’s recent work on marijuana policy. Meanwhile, the amendment enjoys support from a coalition of fiscally conservative thought…
Marijuana Moment
Federal Government Violated the Law in Marijuana Scheduling Evaluation, Group Says
Marijuana Moment cites Senior Fellow Michelle Minton’s request for correction on the Department of Health and Human Services’ medical marijuana evaluation. The Competitive…
Blog
Department of Health and Human Services Needs to Correct Record on Marijuana
Regulators at the federal Drug Enforcement Agency (DEA) had an opportunity in 2016 to move marijuana into a less restrictive category of controlled substances. This…
Real Clear Policy
Federal Pot Prohibition Nears its End
America has made up its mind on marijuana. Most Americans think it should be legal, and all but two states have decriminalized or legalized the drug in…
News Release
CEI Report Calls for Elimination of EPA’s Flawed Integrated Risk Information System
A new report released today by the Competitive Enterprise Institute (CEI) shows EPA’s Integrated Risk Information System (IRIS) has significant problems with methodology, relies on…
Study
EPA’s Flawed IRIS Program Is Far from Gold Standard
Environmental activists claim that the U.S. Environmental Protection Agency’s Integrated Risk Information System (IRIS) represents the gold standard for risk assessment.[i] In…
Products
Free to Prosper: Food, Drugs, and Consumer Freedom
View the full chapter on food, drugs, and consumer freedom here Few matters are as important to consumers as the foods they eat, the…
Blog
One Year Later, Federal Plan on Tobacco Harm Reduction Needs Improvement
The Food and Drug Administration has failed to approve a single reduced-harm nicotine product in the past year, despite unveiling a new “roadmap” in…
Blog
Growing Human Organs for Fun and Profit
Our friends at Freethink Media have an excellent new video out about medical innovation—in this case, how a new company is developing…
The Washington Examiner
Trump Keeps His Promise, Dying Patients Get a Second Chance At Life
The Washington Examiner cited the Competitive Enterprise Institute on the direct toll to human life that regulations impose as a result of ever-increasing FDA clinical…
The Hill
‘Right to Try’ Is a Win for Patient Rights and President Trump
The Hill cited the Competitive Enterprise Institute on the overwhelming cost of compliance which taxes the American economy and in this case limits pharmaceutical ingenuity…
Blog
Congress Could Give Desperate Patients ‘Right to Try’ Experimental Medications
The House of Representatives will soon vote on a companion bill to S. 204, the Right to Try Act. This bill would prevent the…
U.S. News & World Report
Don’t Blunt the Marijuana Revolution
U.S. News & World Report covers the coalition letter, led by CEI, advocating for the Rohrabacher medical marijuana amendment. America is undergoing a somewhat…
Blog
Ohio Drug Price Initiative Gives Taxpayer Money to Unnecessary Lawyers
Lawyers and allied interest groups have long enriched themselves at taxpayers’ expense. But usually, it has been by bringing lawsuits, not defending them.
VapingPost
In-Flight Vaping Ban Upheld
VapingPost covers CEI’s objection to a DOT vaping ban on airplanes. In another blow to American vapers, the Consumer Advocates for Smoke-free…
The Hill
The FDA Shouldn’t Give Into Irrational E-Cigarette Fears
The Food and Drug Administration is now on the wrong side of a new anti-vaping campaign. Instead of helping teens reject using tobacco or e-cigarettes,…
Star Tribune
Menthol Limits: Ban Could Close Vaping Escape Hatch for Smokers
Almost half a million people in our country die from smoking-related illnesses every year. But instead of helping people quit, anti-smoking activists seem to prioritize…
The Fix
Vaping Ban Upheld By Federal Court
The Fix discusses the Department of Transportation e-cigarette ban with Sam Kazman. A federal court has stamped out a challenge to the Department of…
Bloomberg
‘No Smoking’ Also Applies to E-Cigarettes on Flights, Court Says
Bloomberg covers a lawsuit CEI filed against the Department of Transportation airplane e-cigarette ban. Vaping is smoking, a federal appeals court ruled, upholding…
The Hill
Court Upholds Obama Rule Banning Vaping on Airplanes
The Hill covers a lawsuit filed by CEI against the Department of Transportation’s airplane vaping ban. A federal appeals court Friday upheld an…
The Wall Street Journal
Courts Rule E-Cigarettes Should Be Regulated Like Tobacco Products
The Wall Street Journal covers a lawsuit filed by CEI challenging the Department of Transportation’s ban on vaping on airplanes. A federal court…
Tyler Morning Telegraph
Editorial: Vaping Saves Lives by Helping Smokers Quit
Tyler Morning Telegraph discusses regulations on vapes with Michelle Minton. Harm reduction is a vital component in public health decisions. That’s why the…
Inside Sources
Health Departments Lobbying Against E-Cigs Are Robbing Taxpayers, Harming Public Health
Inside Sources covers CEI’s support of the FDA Deeming Authority Clarification Act of 2017. As if the Food and Drug Administration’s deeming regulations…
Blog
Hans Rosling, Antidote to Pessimism, Dies at 68
Hans Rosling, the Swedish doctor and professor who saved countless lives in the world’s poorest countries (and gave TED talks), has died of pancreatic cancer.
Blog
Tom Price Should Focus on Reversing ‘Mission Creep’ at HHS
If confirmed as Secretary of Health and Human Services, Rep. Tom Price should reverse decades of mission creep and refocus federal health agencies on their…
Blog
RealClear Radio Hour: Cancer Care, Chaos, and Climate
This week on RealClear Radio Hour, Drs. Debra Patt and Kerry Emanuel discuss the politics of cancer care, chaos theory, and climate science.
Blog
Senate Democrats Block Anti-Zika Bill Yet Again
Democrats in the Senate have blocked a bill that would have provided federal funds to combat the spread of the Zika virus, reports The Hill.
Blog
New Drug Price Proposal Light on Competition, Heavy on Bureaucracy
Last Friday, Hillary Clinton announced a new plan to “respond to unjustified price hikes” on certain pharmaceutical drugs.
Blog
RealClear Radio Hour: American Indian, EpiPen, and Free Speech Fiascos
In this episode of RealClear Radio Hour, we discuss the fiascos of government overreach and overregulation—on American Indian reservations, in the EpiPen saga, and with…
Blog
CEI Files Opening Brief in “Vapes on a Plane” Lawsuit
Today, CEI filed its opening brief against the U.S. Department of Transportation (DOT), Office of the Secretary of Transportation’s March final rule prohibiting electronic cigarette…
Blog
Q&A on the FDA’s New E-Cigarette Rules
After years of waiting and fighting, the new rules put forth by the U.S. Food and Drug Administration (FDA) on electronic cigarettes and other non-cigarette…
Blog
RealClear Radio Hour: War on Cancer
In this week’s episode of RealClear Radio Hour, we tackle the war on cancer. Disruptive innovators, Stephen Bonner and Paul Davies, confront bureaucracy and big…
Blog
Deflate Drug Prices by Reforming the FDA
This Wednesday, the Senate Select Committee on Aging will hold a hearing on “sudden price spikes” among certain off-patent drugs. The most widely publicized of these…
Blog
A Big Payoff for Patient Investors
There’s a fascinating story in The New York Times this week about pharmaceutical companies and the process of discovering new drugs. Fifteen years ago, the…
Study
Compound Fracture
Drug compounding involves reformulating or repackaging approved medicines to better tailor them to patients’ needs. Adding new federal regulations to further restrict compounding would do…
News Release
A Second Federal Court Green-Lights Lawsuit Against Obamacare
WASHINGTON, Oct. 31 – A second federal judge Thursday has ruled a lawsuit that challenges a major IRS Obamacare regulation could proceed despite the government’s…
Cheap Over-the-Counter STD Test Turbocharges Casual Sex
Cheap Over-the-Counter STD Test Turbocharges Casual Sex
Imagine you’re a young Millennial prowling for a hookup. It looks like tonight might be your night. But when the magic moment arrives, instead of…
The Hill
State-based drug tracking puts Americans at risk
When consumers take prescription and over-the-counter drugs — as more than half of all Americans do each month — they expect those medicines to improve…
Forbes
Gay Marriage, Polygamy, Bestiality, Abortion, Infanticide, Pot, Foie Gras, Plastic Bags, Big Gulps and Democracy
Consider the following list: 1) Marry someone of your same gender, 2) join a harem, 3) have sex with your donkey, 4) kill your baby the…
Bloomberg
Ignore Hysteria Over New ‘Monsanto’ Bill
Greg Conko, who studies biotech issues for the libertarian Competitive Enterprise Institute, points out that this fear is overblown, since organic standards require farmers to…
Forbes
FTC Drug Meddling Would Needlessly Push Pharmaceutical Costs Higher
Four of every five pharmaceutical prescriptions today are filled with a generic drug. That sounds like a big number, but the Federal Trade Commission (FTC)…
Heartlander
GMO Labeling to Appear on Washington Ballot
Gregory Conko, a senior fellow at the Competitive Enterprise Institute, says consumers have a right to know if products they purchase have negative health consequences.
News Release
Institute Welcomes Court Ruling on Commercial Free Speech
WASHINGTON, D.C., Dec. 4, 2012 – The Competitive Enterprise Institute applauded the U.S. Second Circuit Court of Appeals decision yesterday, concluding that the…
Hoover Institution
Free Speech for Big Pharma
One of the most important elements of medicine is also among the least well known: the ability of physicians to prescribe approved medicines for purposes…
Forbes
“Genetically Engineered” In California: A Food Label We Don’t Need
From “food miles” to farmers’ markets, it seems that consumers have never been more interested in the ways their food is grown. That’s one motivation…
Forbes
Labeling Of Genetically Engineered Foods Is A Losing Proposition
As Joe Six-pack munches Fritos and popcorn during the opening games of the NFL season, does he care what variety of corn was used to…
USA Today
FDA rules won’t do much good
Food-borne illnesses kill as many as 3,000 Americans each year, but consumers should not expect new Food and Drug Administration regulations to help. These rules,…
Real Clear Policy
More FDA Control Does Not Mean More Safety
News outlets are reporting that the U.S. Food and Drug Administration (FDA) has cited an alarmingly high number of alleged safety and regulatory violations by…
Real Clear Markets
Global Governments’ Growing Embrace of Big Pharma
As the pharmaceutical industry wrestles with multiple existential threats-from price controls to patent cliffs to dwindling pipelines-calls are growing for deeper government-industry cooperation. As private…
Washington Times
High Price of Cheap Drug Imports
With the Senate set to vote on one of the few “must-pass” bills of the year, pharmaceutical industry critics are plotting ways to add poison…
Washington Times
ObamaCare’s Killer Device Tax
Much of the political conversation in Washington these days concerns innovation, job creation and competitiveness. But talk is cheap, and elected officials must enact policies…
Washington Times
The Off-Label Drug War of Words
If knowledge is power and ignorance is bliss, what is power used to prevent knowledge from eliminating ignorance? I don’t know; ask the FDA (U.S.
Heartlander
Critical Drug Shortages Reaching Crisis
From Ashley Bateman's article on Heartland.org: But according to Greg Conko, a senior fellow at the Competitive Enterprise Institute, more mandates on companies…
Medical Progress Today
Mayo v. Prometheus and Diagnostic Patents: What Does the Supreme Court Decision Really Mean?
I finally had a chance to read the Supreme Court's recent decision in the Mayo v. Prometheus Labs case, which invalided two patents claiming methods…
Medical Progress Today
The Orphan Drug Conundrum
It’s not a crisis. Yet. Bigger health care issues loom. Right now. There are still fortunes to be made. While it lasts. But one could…
Medical Progress Today
Seeking Solution to “Incredibly Complex” Issue of Drug Shortages
Medical Progress Today
The FDA vs. Commercial Speech
The ability of physicians to prescribe approved medicines for purposes not sanctioned by the Food and Drug Administration (FDA) is one of the most important…
Medical Progress Today
The 510(k) Program Should Be Saved, Not Scorned
Medical Progress Today